43
Participants
Start Date
March 7, 2011
Primary Completion Date
April 13, 2020
Study Completion Date
May 9, 2020
Midostaurin
Midostaurin 25 mg soft gelatin capsules (2 capsules). The midostaurin capsules will be administered orally with 240 mL of non-carbonated water in the morning (between 8-10 AM), and in the evening (after a 12 hour break) from Day 1 to Day 6. On Day 7, midostaurin will be administered in the morning only (between 8-10 AM).
Midostaurin
Midostaurin 25 mg soft gelatin capsules (2 capsules). The midostaurin capsules will be administered orally with 240 mL of non-carbonated water in the morning (between 8-10 AM) on Day 1 only.
Novartis Investigative Site, Brussels
Novartis Investigative Site, Sofia
Novartis Investigative Site, Berlin
Novartis Investigative Site, Frankfurt
American Research Corporation Inc, San Antonio
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Kaunas
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY